Event Brief
Jan 11, 2026 at 9:06 PM ET
SK Biopharmaceuticals Wins U.S. Approval for Trials
By The BriefBrief
SK Biopharmaceuticals has received U.S. approval for clinical trials of its drug candidate.
WHO: SK Biopharmaceuticals Co.
WHAT: Received U.S. approval for clinical trials
WHEN: Jan 11, 2026 at 7:00 PM ET
WHERE: Seoul, South Korea
WHY: To advance the development of its drug candidate
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21417 of 21417
Same format. Every time.
Continue reading — sign in or create a free account with
